undefined

Lomax Ward

General Partner at Outsized Ventures, an early-stage investor in deep tech companies. Based in Lisbon.

Top 3 podcasts with Lomax Ward

Ranked by the Snipd community
undefined
7 snips
Jan 13, 2025 • 1h 7min

EUVC | E398 | This Week in European Tech with Dan Bowyer, Mads Jensen, and Lomax Ward

Lomax Ward, General Partner at Outsized Ventures and an early-stage investor in deep tech based in Lisbon, dives into the heart of Europe's tech scene. They explore the challenges of the semiconductor industry, including funding and political inertia. The conversation shifts to free speech on social media, highlighting the tension between expression and moderation. Lomax also compares Anthropic's rapid valuation to its competitors while stressing the importance of balancing government support for startups to nurture innovation. Tune in for insights on funding disparities and the evolving UK startup ecosystem!
undefined
Oct 11, 2024 • 41min

E367 | EUVC | AI Nobel Prizes, Google’s Search Monopoly, UK’s Economic Shifts, and LP Appetite for VC in 2025 – hosted by Dan Bowyer

Lomax Ward, General Partner at Outsized Ventures, and Mads Jensen, Partner at SuperSeed, join Dan Bowyer to explore pressing themes in European tech. They discuss the significance of AI in the latest Nobel Prizes, scrutinize Google’s monopolistic tendencies, and assess the impact of rising UK borrowing costs on startups. Additionally, they delve into the evolving landscape of venture capital, focusing on Limited Partners’ strategies for 2025 and the role of regulation in fostering innovation. It's an insightful look at the challenges and opportunities within the ecosystem!
undefined
Dec 1, 2024 • 39min

EUVC | E384 | Health Tech Renaissance, ChatGPT Turns Two, Northvolt's Setbacks, and Cradle's AI Success with Dan Bowyer, Mads Jensen & Lomax

Lomax Ward, a General Partner at Outsized Ventures, and Mads Jensen, a Partner at SuperSeed, dive into the vibrant world of health tech. They discuss the transformative power of preventative health scanning and the challenges of hefty health screenings. The conversation shifts to the evolution of AI, celebrating ChatGPT’s impact while addressing potential pitfalls. They also analyze Northvolt's rise and fall, emphasizing the need for better management and cultural attitudes towards failure. Finally, they highlight exciting developments in psychedelics and Cradle Bio’s promising success.